About: Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) wüsseschaftlicher Artikel, wo im April 2000 veröffentlicht worden isch (gsw) наукова стаття, опублікована у квітні 2000 (uk) im April 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'abril de 2000 (ast) scientific article published on 01 April 2000 (en) գիտական հոդված հրատարակված 2000 թվականի ապրիլի 1-ին (hy)
publication date	wds:Q74126218-15BF24C2-9E31-4FD8-A367-0A798CD9B98B
publication date	2000-04-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q74126218-36B7805C-1A3C-419E-A098-A50ADE37A133
exact match	https://scigraph.springernature.com/pub.10.1023/a:1006405504158
cites work	wds:Q74126218-0B196315-C89D-48C1-AD86-F3B7049EC9DD wds:Q74126218-1884C5D7-5578-4684-A118-C6D6038FA073 wds:Q74126218-224AA0DD-25B5-41C1-BDF3-176166A3C0AC wds:Q74126218-360F614B-BC51-46D6-9ACD-72CF4B2132A7 wds:Q74126218-440FA210-5155-4287-8F48-540343B6A3F1 wds:Q74126218-58659259-D5B0-4287-AD2B-461491F076DD wds:Q74126218-690E1C15-97EF-4A1E-BCFD-F638B0784EC8 wds:Q74126218-7B933B95-25DF-4748-AB99-C82231230649 wds:Q74126218-7E59D44B-D929-4513-B9C8-FFFD36CB48F1 wds:Q74126218-8801872F-FFB9-4A8C-A388-2A1675D66F01 wds:Q74126218-90668C7E-A7BB-4887-9EB1-ED4F69220576 wds:Q74126218-A266E31C-C857-41FB-B6CB-D44F8BE68EF7 wds:Q74126218-A4B5DE2D-F1DB-4219-BCA0-4C28434D7D07 wds:Q74126218-C1E5251C-BDDE-4A55-8AF3-D5303799C622 wds:Q74126218-DA9C027B-D6DB-414C-B54C-409ECCA7369B wds:Q74126218-F43EB045-181C-4D92-8FAF-96AEBBBC40C5 wds:Q74126218-F5F2DF1E-A504-4763-A667-D91C72C0F766
cites work	Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas Cancer of the breast: Size of neoplasm and prognosis The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update Predicting recurrence and survival in breast cancer. A panel discussion Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study Rapid and prognostically valid quantification of immunohistochemical reactions by immunohistometry of the most positive tumour focus. A prospective follow-up study on breast cancer using antibodies against MIB-1, PCNA, ER, and PR. Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up Evaluation of lymphocyte immunity in breast cancer patients Cancer prognosis predicted by preoperative lymphocyte responsiveness in vitro Biological markers and breast cancer. A multiparametric study. II. Depressed immune competence Cell-Mediated Immune Responses of Breast Cancer Patients to Autologous Tumor-Associated Antigens2 Tumor marker kinetics in the monitoring of breast cancer Phytohaemagglutinin responsiveness of peripheral lymphocytes and survival in patients with primary breast cancer
author name string	wds:Q74126218-6083358F-3B4D-4BD9-AB48-8629AE3F31B8 wds:Q74126218-F00EA4C2-C5C9-491F-A725-05E1A8D2175E wds:Q74126218-FAA36532-B6C0-45FE-B78D-5628ADAF2708
author name string	J A Petros R Rucker J L Mccoy
rdfs:label	Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status (en) Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status (nl)
skos:prefLabel	Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status (en) Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status (nl)
name	Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status (en) Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status (nl)
title	wds:Q74126218-8E33CF81-BD24-40C8-96D5-31AA73008D05
title	Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status (en)
page(s)	wds:Q74126218-AD8C35DB-9FAC-4FFC-9C35-CEC0D163F424
page(s)	227-234
instance of	wds:Q74126218-DE7652D9-1F2F-4CD8-8BCE-56BEEF4A9ECF
instance of	scholarly article
main subject	wds:Q74126218-A07C164A-FB86-4EC0-8BAA-865612121014
main subject	breast cancer
PubMed ID	wds:Q74126218-BA836D2F-419D-4422-A64F-86F8763BC8EB
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10930110
PubMed ID	10930110
published in	wds:Q74126218-74BF0E15-6D03-471A-88E0-A05FDDDD8428
published in	Breast Cancer Research and Treatment
issue	wds:Q74126218-EB3136AD-5F45-4D55-A942-EB0866EEC1C7
volume	wds:Q74126218-7B637186-8D72-4C4B-97EC-3E560FE73E7A
issue	3
volume	60
DOI	wds:Q74126218-9F5927EC-012A-49BC-B788-392F02A4B16B
DOI	http://dx.doi.org/10.1023/A:1006405504158
DOI	10.1023/A:1006405504158
Dimensions Publication ID	wds:Q74126218-EE7963E0-29C1-4C28-B6B7-9D426EFA0A46
Dimensions Publication ID	1044552486
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74126218
is cites work of	The role of neurokinin-1 receptor in the microenvironment of inflammation and cancer A new approach to reducing postsurgical cancer recurrence: perioperative targeting of catecholamines and prostaglandins Potential Prophylactic Measures Against Postoperative Immunosuppression: Could They Reduce Recurrence Rates in Oncological Patients? CpG-C oligodeoxynucleotides limit the deleterious effects of beta-adrenoceptor stimulation on NK cytotoxicity and metastatic dissemination Prostaglandin E2 Suppresses NK Activity In Vivo and Promotes Postoperative Tumor Metastasis in Rats Lymphocyte subpopulation and dendritic cell phenotyping during antineoplastic therapy in human solid tumors The peripheral blood leukocyte phenotype in patients with breast cancer: effect of doxorubicin/paclitaxel combination chemotherapy Exploiting the critical perioperative period to improve long-term cancer outcomes Biobehavioral influences on cancer progression Blood transfusion promotes cancer progression: a critical role for aged erythrocytes Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvement Cognitive-behavioral stress management increases benefit finding and immune function among women with early-stage breast cancer The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents Surgery as a double-edged sword: a clinically feasible approach to overcome the metastasis-promoting effects of surgery by blunting stress and prostaglandin responses Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCR Safety of Therapeutic Fever Induction in Cancer Patients Using Approved PAMP Drugs. Effects of a Chinese medical herbs complex on cellular immunity and toxicity-related conditions of breast cancer patients The identification of clinically relevant markers and therapeutic targets

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software